High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast

Abstract

The purpose of this study was to determine outcomes for 56 patients with inflammatory breast cancer (IBC) receiving high-dose chemotherapy (HDC) with cyclophosphamide, thiotepa and carboplatin (CTCb) with peripheral blood stem cell (PBSC) support. All patients received the same total amount of chemotherapy but there were differences in the sequence of… (More)
DOI: 10.1038/sj.bmt.1701965

Topics

4 Figures and Tables

Cite this paper

@article{Schwartzberg1999HighdoseCW, title={High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast}, author={L S Schwartzberg and C H Weaver and Lawrence M. Lewkow and Barbara McAneny and Bi-xian Zhen and Rhiannon Birch and W H West and K W Tauer and C. Dean Buckner}, journal={Bone Marrow Transplantation}, year={1999}, volume={24}, pages={981-987} }